global
pandem
unpreced
health
emerg
insuffici
access
test
hamper
effect
public
health
intervent
patient
care
manag
number
countri
furthermor
avail
regulatoryclear
reagent
challeng
widespread
implement
test
rapidli
develop
qrtpcr
detect
assay
use
format
test
analyt
perform
across
multipl
nucleic
acid
extract
kit
data
show
robust
analyt
accuraci
residu
clinic
biospecimen
limit
detect
sensit
specif
confirm
current
avail
commerci
reagent
method
result
provid
valuabl
inform
highcomplex
laboratori
seek
develop
effect
local
laboratorydevelop
procedur
highthroughput
capabl
detect
coronaviru
diseas
newli
emerg
pandem
infecti
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
easili
transmit
among
human
infect
least
peopl
caus
death
march
john
hopkin
coronaviru
resourc
center
need
widespread
test
among
individu
symptom
health
care
worker
individu
contact
infect
individu
need
curb
spread
prefer
method
diagnosi
coronaviru
infect
onestep
quantit
revers
transcriptas
pcr
qrtpcr
major
qrtpcr
procedur
rna
must
extract
patient
sampl
present
patient
sampl
must
inactiv
lysi
step
rna
extract
safeti
individu
work
sampl
cdc
confirm
use
sever
rna
extract
kit
extern
lysi
buffer
effect
inactiv
unfortun
access
kit
sever
limit
hamper
widespread
implement
test
valid
new
rna
extract
kit
qrtpcr
reagent
desper
need
eas
suppli
constraint
increas
test
worldwid
two
cdc
approv
kit
qiamp
viral
rna
kit
qiagen
easymag
nuclisen
kit
lysi
buffer
contain
guanidinium
thiocyan
guanidin
thiocyan
respect
third
kit
nucleospin
viru
rnadna
extract
kit
macheri
nagel
takara
current
cdc
approv
contain
guanidin
hydrochlorid
lysi
buffer
compar
three
extract
method
perform
qrtpcr
ruo
primerprob
set
target
cdc
approv
human
rnase
p
rp
sequenc
respond
current
shortag
reagent
avail
develop
lower
volum
qrtpcr
assay
altern
singl
step
master
mix
data
demonstr
three
rna
extract
kit
use
laboratorydevelop
procedur
effect
detect
reduc
input
qrtpcr
reaction
volum
still
provid
sensit
detect
copi
viral
genom
per
microlit
compar
previous
valid
method
synthet
standard
control
exact
diagnost
abbrevi
edx
viral
nucleic
acid
human
gdna
dilut
edx
neg
control
human
indic
edx
control
manufactur
requir
extract
procedur
serv
synthet
spikein
sourc
valid
entir
assay
procedur
ddpcr
qualiti
control
copi
number
synthet
viral
rna
sourc
acquir
bei
atcc
genom
isol
acquir
bei
plasmid
cdna
acquir
idt
encod
relev
target
sequenc
well
sar
mer
virus
serv
specif
control
human
rp
control
nonidentifi
residu
clinic
biospecimen
provid
minnesota
depart
health
mdh
use
common
rule
exempt
sampl
track
laboratori
inform
manag
system
lim
throughout
process
access
data
releas
contain
barcod
use
trace
includ
phi
initi
scan
lim
uniqu
sampl
swab
barcod
associ
uniqu
tube
micron
extract
rna
elut
complet
extract
rack
barcod
tube
extract
batch
arrang
runplat
layout
bottomscan
confirm
well
locat
lim
gener
pcr
run
plate
layout
ingest
rtpcr
result
file
inspect
interpret
pathologist
gener
report
file
output
import
laboratori
inform
electron
medic
record
system
handl
clinic
sampl
prior
viral
inactiv
use
standard
practic
biosafeti
level
enhanc
person
protect
equip
includ
dispos
gown
face
protect
either
full
shield
mask
eye
protect
tyvek
sleev
doubl
glove
clean
room
tacki
mat
locat
room
threshold
work
patient
sampl
perform
biolog
safeti
cabinet
bsc
includ
centrifug
vortex
heat
addit
precaut
includ
chang
outer
glove
manipul
sampl
prior
remov
hand
bsc
reduc
pipett
speed
minim
aerosol
risk
work
towel
soak
bleach
dispos
pipet
tip
use
clinic
sampl
contain
bleach
viral
inactiv
clinic
sampl
first
place
tube
contain
viral
lysi
buffer
treat
accord
manufactur
protocol
sampl
transfer
new
clean
tube
contain
ethanol
per
next
step
rna
extract
protocol
inactiv
sampl
tube
surfac
decontamin
place
secondari
contain
move
separ
room
remaind
rna
extract
protocol
carri
standard
practic
bsc
person
protect
equip
rna
extract
includ
glove
gown
eye
protect
sampl
extract
use
three
differ
rna
extract
kit
qiagen
qiaamp
viral
rna
mini
kit
abbrevi
qia
catalog
machereynagel
nucelospin
viru
mini
kit
abbrevi
mn
catalog
easymag
nuclisen
system
abbrevi
emag
extract
method
follow
manufactur
recommend
protocol
notabl
except
use
start
materi
elut
appropri
elut
materi
indic
manufactur
protocol
three
separ
rtqpcr
reaction
set
barcod
plate
thermo
scientif
either
rp
primer
probe
extract
rna
ad
qpcr
mastermix
compris
follow
compon
water
gotaq
probe
qpcr
master
mix
dutp
promega
cat
goscripttm
rt
mix
rtqpcr
promega
cat
primerprob
set
either
rp
idt
cat
primer
probe
obtain
idt
cdc
ruo
kit
rxn
idt
cat
cdcrecommend
sequenc
found
web
address
http
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ul
reaction
volum
comparison
reaction
volum
comparison
reaction
scale
uniformli
volum
three
separ
rtqpcr
reaction
set
barcod
plate
thermo
scientif
either
rp
primer
probe
extract
rna
ad
qpcr
mastermix
compris
follow
compon
water
gotaq
probe
qpcr
master
mix
dutp
promega
cat
goscripttm
rt
mix
rtqpcr
promega
cat
primerprob
set
either
rp
idt
qpcr
cycl
condit
reaction
cycl
quantstudio
thermofish
one
cycl
minut
follow
one
cycl
minut
follow
cycl
second
minut
minimum
two
templat
control
ntc
includ
run
baselin
allow
calcul
automat
threshold
select
set
uniformli
run
ct
valu
export
analyz
microsoft
excel
amplif
curv
manual
review
compar
perform
use
annealingextens
temperatur
reaction
cycl
quantstudio
thermofish
one
cycl
minut
follow
one
cycl
minut
follow
cycl
second
minut
determin
reagent
instrument
use
annealingextens
temperatur
recommend
mastermix
manufactur
promega
produc
robust
amplif
data
shown
preliminari
assay
character
initi
pilot
experi
aim
prove
accept
perform
well
assay
format
assay
volum
util
subset
avail
clinic
biospecimen
synthet
posit
extract
control
nucleic
acid
control
test
initi
paramet
confirm
reproduc
determin
initi
limit
detect
one
aliquot
four
clinic
sampl
two
posit
two
neg
three
separ
aliquot
synthet
posit
control
viral
copi
per
microlit
extract
qiagen
viral
rna
reagent
one
cdcapprov
extract
method
uniqu
extract
run
pcr
replic
clinic
replic
synthet
replic
sampl
show
expect
posit
viral
gene
target
detect
intern
human
rp
gene
control
detect
neg
undetermin
rp
detect
result
across
replic
averag
ct
valu
demonstr
narrow
standard
deviat
across
extract
pcr
replic
tabl
test
fivefold
dilut
input
rna
nucleas
free
water
sampl
dilut
remain
posit
demonstr
delta
ct
valu
rang
viral
target
tabl
intern
human
control
rp
gene
target
show
greatest
amount
delta
ct
variabl
test
synthet
nucleic
acid
control
integr
dna
technolog
extract
rna
clinic
isol
also
use
direct
pcr
input
demonstr
specif
assay
clinic
isol
plasmid
control
posit
reaction
neg
rp
expect
sar
mer
nucleic
acid
specif
control
run
triplic
neg
three
target
also
expect
tabl
pilot
experi
perform
initi
limit
detect
use
two
separ
synthet
rna
sourc
bei
atcc
dilut
seri
rang
approxim
viral
copi
per
microlit
assay
success
detect
sampl
calcul
lower
boundari
maximum
observ
ct
valu
tabl
preliminari
experi
also
includ
parallel
assess
assay
format
mimick
volum
setup
cdcspecifi
assay
set
pcr
replic
subset
sampl
volum
format
compar
averag
ct
coeffici
variat
cv
volum
format
key
object
determin
decreas
sampl
input
format
assay
significantli
compromis
assay
perform
comparison
larger
volum
sampl
input
format
observ
small
shift
raw
ct
valu
target
tabl
transform
replic
ct
valu
rel
quantiti
copi
number
calcul
true
quantit
cv
across
data
point
sampletarget
two
assay
format
tabl
copi
number
cv
clinic
sampl
rang
synthet
extract
standard
cv
rang
qualiti
review
amplif
curv
throughout
preliminari
assay
character
experi
perform
optim
threshold
valu
note
artifactu
prime
event
earli
amplif
cycl
would
occasion
produc
nonexponenti
amplif
trace
figur
subset
nonspecif
trace
could
cross
autothreshold
set
instrument
low
threshold
note
preliminari
true
posit
data
point
includ
initi
limit
detect
experi
demonstr
robust
exponenti
amplif
curv
cross
threshold
prior
cycl
artifactu
trace
reach
cutoff
therefor
set
threshold
downstream
valid
experi
analyt
accuraci
clinic
biospecimen
analyt
accuraci
evalu
perform
ten
posit
ten
neg
residu
clinic
biospecimen
collect
nasopharyng
oropharyng
npop
combin
swab
univers
transport
medium
sampl
split
three
separ
aliquot
process
independ
qiagen
qia
macherey
nagel
mn
easymag
emag
rna
extract
kit
elut
volum
yield
total
extract
sampl
posit
neg
extract
sampl
correctli
assign
assay
comparison
orthogon
result
outsid
laboratori
tabl
furthermor
ct
valu
uniqu
clinic
sampl
similar
across
three
differ
extract
method
assess
supplement
tabl
calcul
confid
interv
analyt
accuraci
assay
count
everi
uniqu
extract
clinic
sampl
synthet
posit
extract
control
also
count
biolog
uniqu
nucleic
acid
sourc
base
account
true
posit
true
neg
result
tabl
yield
analyt
sensit
ci
analyt
specif
ci
util
synthet
posit
extract
control
synthet
neg
extract
control
valid
lower
limit
detect
assay
extract
control
deliv
synthet
transport
matrix
includ
human
gdna
dilut
viral
standard
control
neg
extract
control
matrix
contain
human
gdna
achiev
final
viral
target
copi
per
microlit
perform
extract
aliquot
copi
number
target
use
combin
qiagen
macherey
nagel
extract
kit
pcr
replic
perform
uniqu
extract
viral
input
extract
success
detect
replic
tabl
establish
reliabl
limit
detect
lod
averag
ct
lod
qiagen
extract
macherey
nagel
extract
averag
ct
valu
respect
overal
experi
accuraci
limit
detect
one
ten
pcr
replic
input
level
return
inconclus
result
detect
analyt
precis
reproduc
result
rna
replic
clinic
sampl
synthet
genom
isol
control
character
across
valid
experi
test
total
replic
sampl
pair
includ
limit
detect
replic
describ
compar
across
separ
pcr
plate
interrun
complet
concord
clinic
sampl
pair
control
sampl
pair
tabl
within
singl
pcr
plate
intrarun
show
concord
clinic
sampl
control
sampl
pair
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
use
combin
emerg
use
author
eua
research
use
ruo
reagent
multidisciplinari
clinic
scienc
team
abl
valid
analyt
perform
detect
assay
short
time
frame
day
face
extraordinari
barrier
acquisit
euaclear
reagent
result
demonstr
robust
perform
volum
format
qrtpcr
quantstudio
instrument
use
ruo
promega
onestep
mastermix
format
support
test
throughput
increas
number
reaction
possibl
current
landscap
scarc
reagent
result
also
demonstr
suitabl
perform
machereynagel
nucelospin
viru
extract
kit
comparison
two
eua
method
develop
robust
biosafeti
specimen
handl
procedur
ensur
safeti
laboratori
staff
custom
informat
system
promot
scalabl
sampl
access
test
result
given
immens
scale
pandem
predict
reagent
shortag
test
continu
problem
abil
highcomplex
colleg
american
compliant
laboratori
rapidli
reliabl
adapt
local
develop
valid
test
procedur
play
key
role
unit
state
abil
confront
clinic
need
group
recent
provid
import
data
rel
perform
differ
primerprob
set
intriguingli
bruce
et
al
provid
data
indic
qrtpcr
detect
could
success
nasopharyng
swab
sampl
without
prior
rna
extract
least
screen
mechan
innov
rapid
robust
develop
valid
new
laboratori
develop
procedur
requir
help
address
pandem
set
work
provid
blueprint
rapid
character
new
assay
compon
approach
futur
suppli
chain
shortag
emerg
na
na
na
na
na
na
na
na
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
na
na
na
na
figur
repres
amplif
curv
known
neg
sampl
exponenti
amplif
curv
rp
intern
control
target
shown
red
nonspecif
nonexponenti
curv
either
target
shown
blue
threshold
set
protect
potenti
fals
posit
call
ccbynd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
